How many stocks does LOOMIS SAYLES & CO L P own?

As of Q2 2024, LOOMIS SAYLES & CO L P holds 711 positions in their 13F portfolio.

What is LOOMIS SAYLES & CO L P's largest holding?

NVDA at 7.8% of portfolio, worth $5.7B.

What is LOOMIS SAYLES & CO L P's total portfolio value?

$72.6B as of Q2 2024, tracked across 711 holdings.

Is LOOMIS SAYLES & CO L P a hedge fund?

LOOMIS SAYLES & CO L P is an institutional investment manager required to file SEC 13F reports. This includes hedge funds, mutual funds, pension funds, and other institutions managing over $100M.

How often does LOOMIS SAYLES & CO L P report?

13F filings are due quarterly, approximately 45 days after each quarter end.

How has LOOMIS SAYLES & CO L P's portfolio changed in Q2 2024?

View LOOMIS SAYLES & CO L P's latest portfolio changes, new positions, and exits for Q2 2024 on HoldingsIntel.

What is LOOMIS SAYLES & CO L P's investment strategy?

LOOMIS SAYLES & CO L P is classified as a Steady Compounder fund based on HoldingsIntel's Fund DNA analysis of 6 behavioral dimensions.

LOOMIS SAYLES & CO L P

Institutional investor · Portfolio as of Q2 2024

SEC EDGAR SourceSEC Filings

$72.6B

AUM

711

Positions

Q2 2024

Filing

Rating · 2.5

Quarterly Portfolio Change

Activity profile

$ moved · Q2'24

New5%Increased60%Decreased31%Exited4%

Composition

Equity vs derivatives

Equity100%Puts0%Calls0%

Holding period

Avg 3.7 years

<1Q5%1-4Q9%1-2Y9%2Y+76%

Q2 2024 Summary

Active quarter - 74 new positions, 59 exits, 304 increased. Top move: NVDA (INCREASED, conviction 100). Portfolio: $72.6B across 711 positions.

Portfolio Allocation

Top holdings by portfolio weight

NVDA7.84%

META5.78%

AMZN5.37%

GOOGL4.73%

TSLA4.46%

NFLX4.08%

MSFT3.96%

BA3.72%

ORCL3.70%

V3.64%

Other2.47%

Sector Breakdown

Portfolio allocation by GICS sector

Technology28.75%

Communication Services18.40%

Consumer Cyclical15.57%

Healthcare13.61%

Financial Services9.19%

Industrials8.60%

Consumer Defensive3.01%

Energy1.04%

Unknown0.89%

Basic Materials0.74%

Other0.19%

Fund DNA

Behavioral investing profile

Steady Compounder85%- primarily Technology, Communication Services, Consumer Cyclical

Compare DNA across all funds

Fund Rating

7-dimension quality assessment

Solid(2.5 / 5.0)

Track Record65

Conviction40

Concentration0

Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Top Winners

MTSI18Q held

MACOM TECH SOLUTIONS HLDGS I

Avg $23.68 · $68.4M est. P&L

Est. P&L

+370.81%

MSFT23Q held

MICROSOFT CORP

Avg $98.79 · $2.2B est. P&L

Est. P&L

+347.38%

MPWR23Q held

MONOLITHIC PWR SYS INC

Avg $182.78 · $84,332 est. P&L

Est. P&L

+344.31%

Top Losers

Upgrade to Pro to see the worst-performing positions.

View plans

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Holdings711 positions

Export CSV(Pro)

Activity:

Stock	Shares	Value	Weight	Price Trend	Avg Buy	Est. P&L	Held	Conviction
NVDA NVIDIA CORPORATION	46M	$5.7B	7.8%	—	$112.06	+10.20%	22 qtrssince 2019-Q1	Increased 100
META META PLATFORMS INC	8.3M	$4.2B	5.8%	—	$138.14	+263.22%	23 qtrssince 2018-Q4	Decreased 0
AMZN AMAZON COM INC	20.2M	$3.9B	5.4%	—	$106.79	+80.97%	23 qtrssince 2018-Q4	Decreased 0
GOOGL ALPHABET INC	18.8M	$3.4B	4.7%	—	$95.73	+89.06%	23 qtrssince 2018-Q4	Increased 59
TSLA TESLA INC	16.3M	$3.2B	4.5%	—	$209.24	-5.43%	16 qtrssince 2020-Q3	Increased 67
NFLX NETFLIX INC.	4.4M	$3B	4.1%	—	$29.20	+131.13%	16 qtrssince 2020-Q3	Decreased 0
MSFT MICROSOFT CORP	6.4M	$2.9B	4.0%	—	$98.79	+347.38%	23 qtrssince 2018-Q4	Decreased 0
BA BOEING CO	14.8M	$2.7B	3.7%	—	$187.76	-3.06%	23 qtrssince 2018-Q4	Increased 65
ORCL ORACLE CORP	19M	$2.7B	3.7%	—	$41.42	+234.93%	23 qtrssince 2018-Q4	Increased 59
V VISA INC	10.1M	$2.6B	3.6%	—	$131.28	+97.34%	23 qtrssince 2018-Q4	Decreased 0
CRM SALESFORCE INC	7M	$1.8B	2.5%	—	$174.87	+45.45%	18 qtrssince 2020-Q1	Decreased 0
ADSK AUTODESK INC	6.2M	$1.5B	2.1%	—	$131.65	+87.96%	23 qtrssince 2018-Q4	Increased 55
DIS DISNEY WALT CO	15.2M	$1.5B	2.1%	—	$120.97	-19.55%	23 qtrssince 2018-Q4	Increased 55
VRTX VERTEX PHARMACEUTICALS INC	3.1M	$1.5B	2.0%	—	$189.34	+147.56%	19 qtrssince 2019-Q4	Increased 55
MNST MONSTER BEVERAGE CORP NEW	25.9M	$1.3B	1.8%	—	$38.55	+29.56%	23 qtrssince 2018-Q4	Increased 51
REGN REGENERON PHARMACEUTICALS	1.2M	$1.3B	1.8%	—	$357.99	+191.97%	23 qtrssince 2018-Q4	Increased 51
NVO ADR NOVO-NORDISK A S	8.9M	$1.3B	1.8%	—	$52.98	+161.20%	23 qtrssince 2018-Q4	Increased 50
QCOM QUALCOMM INC	6.1M	$1.2B	1.7%	—	$49.69	+288.05%	23 qtrssince 2018-Q4	Increased 51
SHOP SHOPIFY INC	15.5M	$1B	1.4%	—	$39.76	+66.14%	11 qtrssince 2021-Q4	Increased 58
GOOG ALPHABET INC	5M	$925.3M	1.3%	—	$94.90	+92.06%	23 qtrssince 2018-Q4	Decreased 0
Showing 20 of 711 results.691 more with Pro.PROUpgrade to see all →